Home
Browse All Titles
Sign In
Browse All Titles
The Maudsley Prescribing Guidelines in Psychiatry
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
▶
View All
Common adverse effects of antidepressants
Common withdrawal symptoms with SSRIs and similar drugs.
Communication with patients, adherence relationship
Comorbid alcohol use disorder
Concurrent illnesses, drug interactions in older people
Controlled drugs
Conversion from buprenorphine to Espranor
Corticosteroid agents, psychiatric adverse effects
Countertransference, clinicians
Covert administration of medicines in food and drink, older people
General principles in prescribing in older adults
Covert administration of medicines within food and drink
COX-2 inhibitors, lithium interactions
Creatine kinase, psychotropic agent effects
creatinine clearance (CrCl), renal function assessment
Creatinine phosphokinase, antipsychotic medication monitoring
Cultural beliefs, influencing adherence
Cytisine
clinical effectiveness for smoking cessation
adverse effects
cytochrome (CYP) function
antidepressant interactions with enzymes
enzyme phenotype frequency by ancestry
nicotine/smoking effects
alcohol and substrates for enzymes
caffeine metabolism/clearance
genetics
Psychotropic drugs and cytochrome (CYP) function
co-prescribed with warfarin leading to non-GI bleeding risk
Countertherapeutic use of medication
COVID-19
C-reactive protein in blood, psychotropic agent effects
creatine kinase (CK) elevations, antiretrovirals
Creatinine in blood, psychotropic agent effects
Cross-tapering, switching
Refresh
first
prev
1
2
3
4
30
select
next
last
Displaying items 91 - 114 of 114